Lastacaft
Active Ingredient(s): AlcaftadineFDA Approved: * July 28, 2010
Pharm Company: * VISTAKON PHARMA
Category: Vision / Eye Health
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Lastacaft Overview
Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist.[2] It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft.[3] Contents 1 Pharmacology 2 Clinical relevance 3 Adverse effects 4 Pharmacokinetics 5 Sales 6 See also 7 References 8 External links Pharmacology Alcaftadine is an antagonist at three of the histamine receptors (1, 2 a...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alcaftadine
Recent Lastacaft Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Alcaftadine
- Solution/drops: 0.25%
NDC Database Records for Lastacaft: (3 results)
Sorted by National Drug Code- 0023-4290 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Allergan, Inc.
- 42254-288 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Rebel Distributors Corp
- 54868-6294 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Physicians Total Care, Inc.